Amarin said late Tuesday that it has settled its lawsuit with Ivax over two patents for Permax, a treatment for Parkinson's disease that was licensed to Amarin by Eli Lilly . The two patents were ...

The purchase would give Valeant the rights to the Parkinson’s disease drug Permax and to Zelapar, another Parkinson’s treatment being developed by Elan Corp. and Cardinal Health Inc.’s RP ...

A study by Italian researchers found that roughly one-fourth of Parkinson’s patients taking pergolide or cabergoline, sold as Permax, Dostinex and other brands, had moderate to severe heart ...

The products being withdrawn are Permax, the trade name for pergolide marketed by Valeant Pharmaceuticals, and two generic versions of pergolide manufactured by Par and Teva.

A man from Rotterdam who became a gambling addict after taking drugs to control Parkinson’s disease may be entitled to compensation, a Dutch court has ruled. The addiction to gambling led to the ...

Pat Galea, 65, lost about $700,000 on poker machines after taking both Permax and Cabaser for about a decade for restless legs syndrome, which creates an urge for sufferers to move their legs.

MORE than 100 people who allegedly became addicted to gambling and pornography after taking a prescription drug used to treat tremors associated with Parkinson's disease are suing two drug companies.

The Food and Drug Administration said Thursday that pergolide, sold under the name Permax and also in generic versions, is being withdrawn at the agency’s request.

Although Permax was originally brought to market by Eli Lilly, it is now marketed in the United States by Valeant Pharmaceuticals International and in Canada by Shire.